Singular Genomics Other Liab Over Time
| OMIC Stock | USD 21.42 0.48 2.19% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Singular Genomics Performance and Singular Genomics Correlation. Singular |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Singular Genomics. If investors know Singular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Singular Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (34.68) | Revenue Per Share 1.107 | Quarterly Revenue Growth 0.459 | Return On Assets (0.24) | Return On Equity (0.52) |
The market value of Singular Genomics Systems is measured differently than its book value, which is the value of Singular that is recorded on the company's balance sheet. Investors also form their own opinion of Singular Genomics' value that differs from its market value or its book value, called intrinsic value, which is Singular Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Singular Genomics' market value can be influenced by many factors that don't directly affect Singular Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Singular Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Singular Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Singular Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Liab Analysis
Compare Singular Genomics Systems and related stocks such as InfuSystems Holdings, Pro Dex, and LeMaitre Vascular Other Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INFU | 221 K | 415 K | 66 K | 66 K | 66 K | 66 K | 66 K | 69 K | 104 K | 104 K | 104 K | 104 K | 104 K | 93.6 K | 170.8 K |
| PDEX | 245 K | 284 K | 270 K | 243 K | 274 K | 68 K | 220 K | 220 K | 308 K | 804 K | 397 K | 544 K | 8 K | 9.2 K | 8.7 K |
| LMAT | 344 K | 71 K | 105 K | 249 K | 325 K | 2.5 M | 3.9 M | 3.4 M | 3.1 M | 5.4 M | 4.8 M | 2.8 M | 2.2 M | 2.6 M | 1.8 M |
| UTMD | 522 K | 522 K | 363 K | 6.6 M | 6.6 M | 5.5 M | 3.9 M | 9.3 M | 5.5 M | 4.9 M | 4.8 M | 4.5 M | 3.3 M | 3.8 M | 4.9 M |
| MLSS | 1.1 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.6 M | 1.7 M |
| ANGO | 9.8 M | 327 K | 66.3 M | 56.5 M | 38.5 M | 47.9 M | 30.1 M | 19 M | 23.9 M | 39.6 M | 37.1 M | 24.2 M | 17.4 M | 20 M | 32.6 M |
| ATR | 14.9 M | 67.6 M | 102.3 M | 77.7 M | 114.1 M | 114.6 M | 116.9 M | 106.9 M | 139.7 M | 165.9 M | 251.7 M | 267.2 M | 122.5 M | 140.9 M | 99 M |
| KRMD | 168.1 K | 168.1 K | 168.1 K | 168.1 K | 168.1 K | 168.1 K | 104.9 K | 25.4 K | 25.4 K | 25.4 K | 25.4 K | 25.4 K | 25.4 K | 22.9 K | 21.7 K |
| POCI | 500 K | 500 K | 500 K | 500 K | 500 K | 500 K | 500 K | 500 K | 500 K | 333.3 K | 166.7 K | 705.9 K | 705.9 K | 811.8 K | 469.1 K |
| NYXH | 577 K | 577 K | 577 K | 577 K | 577 K | 577 K | 577 K | 577 K | 577 K | 577 K | 37 K | 97 K | 59 K | 53.1 K | 50.4 K |
Singular Genomics Systems and related stocks such as InfuSystems Holdings, Pro Dex, and LeMaitre Vascular Other Liab description
My Equities
My Current Equities and Potential Positions
| Singular Genomics Systems | OMIC |
| Classification | Office Supplies |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 21.42
Check out Singular Genomics Performance and Singular Genomics Correlation. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Singular Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.